Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial

Sadaf Oliai Araghi; Jessica Jong; Suzanne Boon - van Dijk; KMA Swart; HW van Laarhoven; NM Schoor; L Groot; Valery Lemmens; Bruno Stricker; André Uitterlinden; Nathalie van der Velde

doi:10.1158/1055-9965.Epi-17-1198

Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial

Sadaf Oliai Araghi
, Jessica Jong
, Suzanne Boon - van Dijk
, KMA Swart
, HW van Laarhoven
, NM Schoor
, L Groot
, Valery Lemmens
, Bruno Stricker
, André Uitterlinden
, Nathalie van der Velde

Research output: Contribution to journal › Article › Academic › peer-review

78 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	275-282
Number of pages	8
Journal	Cancer Epidemiology Biomarkers & Prevention
Volume	28
Issue number	2
DOIs	https://doi.org/10.1158/1055-9965.Epi-17-1198
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-01-39-09-A
EMC NIHES-01-64-03

Access to Document

10.1158/1055-9965.Epi-17-1198

http://hdl.handle.net/1765/117004

Cite this

Oliai Araghi, S., Jong, J., Boon - van Dijk, S., Swart, KMA., van Laarhoven, HW., Schoor, NM., Groot, L., Lemmens, V., Stricker, B., Uitterlinden, A., & van der Velde, N. (2019). Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer Epidemiology Biomarkers & Prevention, 28(2), 275-282. https://doi.org/10.1158/1055-9965.Epi-17-1198

@article{5ad2bad3074d4774a11c37c4d4b2d40f,

title = "Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial",

author = "\{Oliai Araghi\}, Sadaf and Jessica Jong and \{Boon - van Dijk\}, Suzanne and KMA Swart and \{van Laarhoven\}, HW and NM Schoor and L Groot and Valery Lemmens and Bruno Stricker and Andr{\'e} Uitterlinden and \{van der Velde\}, Nathalie",

year = "2019",

doi = "10.1158/1055-9965.Epi-17-1198",

language = "Undefined/Unknown",

volume = "28",

pages = "275--282",

journal = "Cancer Epidemiology Biomarkers \& Prevention",

issn = "1055-9965",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

Oliai Araghi, S, Jong, J, Boon - van Dijk, S, Swart, KMA, van Laarhoven, HW, Schoor, NM, Groot, L, Lemmens, V , Stricker, B, Uitterlinden, A & van der Velde, N 2019, 'Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial', Cancer Epidemiology Biomarkers & Prevention, vol. 28, no. 2, pp. 275-282. https://doi.org/10.1158/1055-9965.Epi-17-1198

Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. / Oliai Araghi, Sadaf; Jong, Jessica; Boon - van Dijk, Suzanne et al.
In: Cancer Epidemiology Biomarkers & Prevention, Vol. 28, No. 2, 2019, p. 275-282.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial

AU - Oliai Araghi, Sadaf

AU - Jong, Jessica

AU - Boon - van Dijk, Suzanne

AU - Swart, KMA

AU - van Laarhoven, HW

AU - Schoor, NM

AU - Groot, L

AU - Lemmens, Valery

AU - Stricker, Bruno

AU - Uitterlinden, André

AU - van der Velde, Nathalie

PY - 2019

Y1 - 2019

U2 - 10.1158/1055-9965.Epi-17-1198

DO - 10.1158/1055-9965.Epi-17-1198

M3 - Article

SN - 1055-9965

VL - 28

SP - 275

EP - 282

JO - Cancer Epidemiology Biomarkers & Prevention

JF - Cancer Epidemiology Biomarkers & Prevention

IS - 2

ER -